Moderna Inc. buy BMO Capital Markets
Start price
12.01.26
/
50%
€29.02
Target price
12.01.27
-
Performance (%)
48.41%
Price
13.05.26
€43.06
Summary
This prediction is currently active. With a performance of 48.41% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 12.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 3.747% | 3.747% |
| iShares Core DAX® | -1,52 % | 0,86 % |
| iShares Nasdaq 100 | 3,36 % | 15,64 % |
| iShares Nikkei 225® | 1,66 % | 8,64 % |
| iShares S&P 500 | 1,61 % | 8,53 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
Ratings data for MRNA provided by MarketBeat